AAPL349.21-3.24 (-0.92%) ▼|ABBV283.54-2.47 (-0.86%) ▼|ABT103.87-0.61 (-0.58%) ▼|ACN218.58-8.91 (-3.92%) ▼|ADBE221.68-4.52 (-2.00%) ▼|AMAT338.93-12.84 (-3.65%) ▼|AMD489.19-40.95 (-7.72%) ▼|AMGN438.82-5.07 (-1.14%) ▼|AMT181.15-3.67 (-1.99%) ▼|AMZN257.37-10.37 (-3.87%) ▼|AVGO346.65-7.40 (-2.09%) ▼|AXP311.11-4.29 (-1.36%) ▼|BA160.51-2.40 (-1.47%) ▼|BAC48.57-0.34 (-0.70%) ▼|BKNG147.32-5.96 (-3.89%) ▼|BLK1,135.81-33.40 (-2.86%) ▼|BMY58.34-1.22 (-2.05%) ▼|BNY144.83-2.97 (-2.01%) ▼|BRK-B572.04-2.58 (-0.45%) ▼|C115.28-2.06 (-1.76%) ▼|CAT537.37-21.40 (-3.83%) ▼|CL96.88-1.97 (-1.99%) ▼|CMCSA24.86-0.38 (-1.51%) ▼|COF181.76-2.54 (-1.38%) ▼|COP134.99+0.59 (+0.44%) ▲|COST1,093.83-2.79 (-0.25%) ▼|CRM183.31-7.09 (-3.72%) ▼|CSCO94.70-2.48 (-2.55%) ▼|CVS80.04-1.31 (-1.61%) ▼|CVX206.50+0.62 (+0.30%) ▲|DE624.89-19.86 (-3.08%) ▼|DHR227.56-1.02 (-0.45%) ▼|DIS120.25-2.11 (-1.72%) ▼|DUK128.86-1.19 (-0.92%) ▼|EMR157.60-4.40 (-2.72%) ▼|FDX314.64-3.67 (-1.15%) ▼|GD347.34-1.70 (-0.49%) ▼|GE318.88-9.22 (-2.81%) ▼|GEV756.28-15.94 (-2.06%) ▼|GILD166.53-2.45 (-1.45%) ▼|GM81.75-0.38 (-0.46%) ▼|GOOG271.02-8.18 (-2.93%) ▼|GOOGL272.66-9.78 (-3.46%) ▼|GS847.53-25.65 (-2.94%) ▼|HD336.68-0.96 (-0.28%) ▼|HON217.84-4.86 (-2.18%) ▼|IBM223.88-4.65 (-2.03%) ▼|INTC55.72+1.05 (+1.92%) ▲|INTU310.02-3.22 (-1.03%) ▼|ISRG407.24-13.71 (-3.26%) ▼|JNJ267.14-5.56 (-2.04%) ▼|JPM320.22-3.89 (-1.20%) ▼|KO96.09-2.00 (-2.04%) ▼|LIN510.21-1.95 (-0.38%) ▼|LLY1,351.12-31.63 (-2.29%) ▼|LMT571.85-6.34 (-1.10%) ▼|LOW219.14-3.64 (-1.63%) ▼|LRCX203.68-7.99 (-3.77%) ▼|MA626.50-16.87 (-2.62%) ▼|MCD272.35-1.68 (-0.61%) ▼|MDLZ65.69-0.88 (-1.31%) ▼|MDT100.61-0.11 (-0.11%) ▼|META596.22-20.16 (-3.27%) ▼|MMM178.47-2.58 (-1.43%) ▼|MO74.68-1.58 (-2.07%) ▼|MRK132.81-4.97 (-3.61%) ▼|MS174.98-6.19 (-3.42%) ▼|MSFT498.30-9.01 (-1.78%) ▼|MU690.44-14.83 (-2.10%) ▼|NEE83.79-0.99 (-1.17%) ▼|NFLX58.46-1.36 (-2.27%) ▼|NKE34.33-1.98 (-5.45%) ▼|NOW88.87-1.72 (-1.90%) ▼|NVDA145.98-4.98 (-3.30%) ▼|ORCL110.57-3.32 (-2.92%) ▼|PEP139.00-2.87 (-2.02%) ▼|PFE27.54-0.52 (-1.85%) ▼|PG167.85-2.44 (-1.43%) ▼|PLTR153.68-2.99 (-1.91%) ▼|PM186.43-6.30 (-3.27%) ▼|QCOM162.01+2.20 (+1.38%) ▲|RTX193.44-4.01 (-2.03%) ▼|SBUX104.47-4.64 (-4.25%) ▼|SCHW92.12-0.44 (-0.48%) ▼|SO93.29-1.12 (-1.19%) ▼|SPG225.22-6.16 (-2.66%) ▼|T21.85-0.10 (-0.46%) ▼|TMO688.75-3.99 (-0.58%) ▼|TMUS162.53-1.49 (-0.91%) ▼|TSLA374.41-9.31 (-2.43%) ▼|TXN285.75-6.68 (-2.28%) ▼|UBER65.60-3.16 (-4.60%) ▼|UNH330.48-19.43 (-5.55%) ▼|UNP290.63-10.27 (-3.41%) ▼|UPS109.11-1.92 (-1.73%) ▼|USB57.26-1.02 (-1.75%) ▼|V402.25-12.97 (-3.12%) ▼|VZ45.74-0.39 (-0.85%) ▼|WFC80.61-0.31 (-0.38%) ▼|WMT126.04-1.32 (-1.04%) ▼|XOM158.93-1.65 (-1.03%) ▼|AAPL349.21-3.24 (-0.92%) ▼|ABBV283.54-2.47 (-0.86%) ▼|ABT103.87-0.61 (-0.58%) ▼|ACN218.58-8.91 (-3.92%) ▼|ADBE221.68-4.52 (-2.00%) ▼|AMAT338.93-12.84 (-3.65%) ▼|AMD489.19-40.95 (-7.72%) ▼|AMGN438.82-5.07 (-1.14%) ▼|AMT181.15-3.67 (-1.99%) ▼|AMZN257.37-10.37 (-3.87%) ▼|AVGO346.65-7.40 (-2.09%) ▼|AXP311.11-4.29 (-1.36%) ▼|BA160.51-2.40 (-1.47%) ▼|BAC48.57-0.34 (-0.70%) ▼|BKNG147.32-5.96 (-3.89%) ▼|BLK1,135.81-33.40 (-2.86%) ▼|BMY58.34-1.22 (-2.05%) ▼|BNY144.83-2.97 (-2.01%) ▼|BRK-B572.04-2.58 (-0.45%) ▼|C115.28-2.06 (-1.76%) ▼|CAT537.37-21.40 (-3.83%) ▼|CL96.88-1.97 (-1.99%) ▼|CMCSA24.86-0.38 (-1.51%) ▼|COF181.76-2.54 (-1.38%) ▼|COP134.99+0.59 (+0.44%) ▲|COST1,093.83-2.79 (-0.25%) ▼|CRM183.31-7.09 (-3.72%) ▼|CSCO94.70-2.48 (-2.55%) ▼|CVS80.04-1.31 (-1.61%) ▼|CVX206.50+0.62 (+0.30%) ▲|DE624.89-19.86 (-3.08%) ▼|DHR227.56-1.02 (-0.45%) ▼|DIS120.25-2.11 (-1.72%) ▼|DUK128.86-1.19 (-0.92%) ▼|EMR157.60-4.40 (-2.72%) ▼|FDX314.64-3.67 (-1.15%) ▼|GD347.34-1.70 (-0.49%) ▼|GE318.88-9.22 (-2.81%) ▼|GEV756.28-15.94 (-2.06%) ▼|GILD166.53-2.45 (-1.45%) ▼|GM81.75-0.38 (-0.46%) ▼|GOOG271.02-8.18 (-2.93%) ▼|GOOGL272.66-9.78 (-3.46%) ▼|GS847.53-25.65 (-2.94%) ▼|HD336.68-0.96 (-0.28%) ▼|HON217.84-4.86 (-2.18%) ▼|IBM223.88-4.65 (-2.03%) ▼|INTC55.72+1.05 (+1.92%) ▲|INTU310.02-3.22 (-1.03%) ▼|ISRG407.24-13.71 (-3.26%) ▼|JNJ267.14-5.56 (-2.04%) ▼|JPM320.22-3.89 (-1.20%) ▼|KO96.09-2.00 (-2.04%) ▼|LIN510.21-1.95 (-0.38%) ▼|LLY1,351.12-31.63 (-2.29%) ▼|LMT571.85-6.34 (-1.10%) ▼|LOW219.14-3.64 (-1.63%) ▼|LRCX203.68-7.99 (-3.77%) ▼|MA626.50-16.87 (-2.62%) ▼|MCD272.35-1.68 (-0.61%) ▼|MDLZ65.69-0.88 (-1.31%) ▼|MDT100.61-0.11 (-0.11%) ▼|META596.22-20.16 (-3.27%) ▼|MMM178.47-2.58 (-1.43%) ▼|MO74.68-1.58 (-2.07%) ▼|MRK132.81-4.97 (-3.61%) ▼|MS174.98-6.19 (-3.42%) ▼|MSFT498.30-9.01 (-1.78%) ▼|MU690.44-14.83 (-2.10%) ▼|NEE83.79-0.99 (-1.17%) ▼|NFLX58.46-1.36 (-2.27%) ▼|NKE34.33-1.98 (-5.45%) ▼|NOW88.87-1.72 (-1.90%) ▼|NVDA145.98-4.98 (-3.30%) ▼|ORCL110.57-3.32 (-2.92%) ▼|PEP139.00-2.87 (-2.02%) ▼|PFE27.54-0.52 (-1.85%) ▼|PG167.85-2.44 (-1.43%) ▼|PLTR153.68-2.99 (-1.91%) ▼|PM186.43-6.30 (-3.27%) ▼|QCOM162.01+2.20 (+1.38%) ▲|RTX193.44-4.01 (-2.03%) ▼|SBUX104.47-4.64 (-4.25%) ▼|SCHW92.12-0.44 (-0.48%) ▼|SO93.29-1.12 (-1.19%) ▼|SPG225.22-6.16 (-2.66%) ▼|T21.85-0.10 (-0.46%) ▼|TMO688.75-3.99 (-0.58%) ▼|TMUS162.53-1.49 (-0.91%) ▼|TSLA374.41-9.31 (-2.43%) ▼|TXN285.75-6.68 (-2.28%) ▼|UBER65.60-3.16 (-4.60%) ▼|UNH330.48-19.43 (-5.55%) ▼|UNP290.63-10.27 (-3.41%) ▼|UPS109.11-1.92 (-1.73%) ▼|USB57.26-1.02 (-1.75%) ▼|V402.25-12.97 (-3.12%) ▼|VZ45.74-0.39 (-0.85%) ▼|WFC80.61-0.31 (-0.38%) ▼|WMT126.04-1.32 (-1.04%) ▼|XOM158.93-1.65 (-1.03%) ▼|
15.6 C
New York
Thursday, November 19, 2026

Tag: FOR

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients

Basel, 15 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new dosing restrictions, effective immediately, for ELEVIDYS™ (delandistrogene moxeparvovec), for non-ambulatory Duchenne muscular dystrophy (DMD) patients, irrespective of age, in both clinical and commercial settings. In the commercial setting, non-ambulatory patients should no longer receive Elevidys. In the clinical trial setting, enrolment and dosing of non-ambulatory patients will be immediately paused until additional risk mitigation measures (e.g. immune modulatory treatment) are implemented in the study protocol. Health authorities, investigators and physicians are being informed so that patient care can be quickly adjusted.

Hisense Celebrates Kick-off of FIFA Club World Cup™ as Official Partner, Marking New Milestone in Global Sports Journey

QINGDAO, China, June 14, 2025 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, celebrates the opening of the FIFA...

20 Textile Enterprises from Qingdao Attended AFF in Tokyo, Japan Hand in Hand

TOKYO, June 15, 2025 /PRNewswire/ -- A report from IQingDao: 2025 Asia Fashion Fair (AFF) grandly opened in Tokyo, Japan on June 9. Organized by...

Cheap AI Bots Eye Junior Coders’ Lunch

In 2007, Luke Arrigoni pulled in $63,000 as a junior software developer. Fast forward to today, and AI tools that supposedly churn out better...

Prix Fitzgerald 2025 Laureate Announced at Hôtel Belles Rives

Renowned American Author Richard Ford Receives 14th Annual Literary Award for Be Mine
Renowned American Author Richard Ford Receives 14th Annual Literary Award for Be Mine

Gold Coast Health Plan Denounces Sharing of Medicaid Enrollment Data with Department of Homeland Security

CAMARILLO, Calif., June 14, 2025 /PRNewswire/ -- Gold Coast Health Plan (GCHP), the local Medi-Cal plan for Ventura County, is deeply concerned about the...

FOX NEWS CHANNEL’S BRET BAIER LANDS FIRST INTERVIEW WITH ISRAELI PRIME MINISTER BENJAMIN NETANYAHU SINCE ISRAEL’S STRIKES ON IRAN ON SUNDAY, JUNE 15TH

NEW YORK, June 14, 2025 /PRNewswire/ -- FOX News Channel's Bret Baier will present a worldwide exclusive live interview with Israeli Prime Minister Bibi Netanyahu on...

RDDT SHAREHOLDERS: Reddit, Inc. Investors are Reminded of the Pending Securities Fraud Investigation – Contact BFA Law (NYSE:RDDT)

Reddit, Inc. investors that lost money are notified to contact BFA Law about its ongoing securities fraud investigation.

OGN SHAREHOLDERS: Organon & Co. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 22 Deadline (NYSE:OGN)

Organon & Co. investors that lost money are notified to contact BFA Law before July 22, 2025 securities fraud class action deadline.

IOVA SHAREHOLDERS: Iovance Biotherapeutics, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 14 Deadline (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. investors that lost money are notified to contact BFA Law before July 14, 2025 securities fraud class action deadline.

FTRE SHAREHOLDERS: Fortrea Holdings Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by August 1 Deadline (NASDAQ:FTRE)

Fortrea Holdings Inc. investors that lost money are notified to contact BFA Law before August 1, 2025 securities fraud class action deadline.

URGN SHAREHOLDERS: UroGen Pharma Ltd. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 28 Deadline (NASDAQ:URGN)

UroGen Pharma Ltd. investors that lost money are notified to contact BFA Law before July 28, 2025 securities fraud class action deadline.

BACXN: Globally Recognized Compliance Certifications and Protection System, Ensuring a Secure Trading Environment

DENVER, June 14, 2025 (GLOBE NEWSWIRE) -- Recently, BACXN has passed compliance regulatory reviews in North America and Southeast Asia, officially launching a cross-jurisdictional risk control and compliance response mechanism. This milestone signifies that the platform not only possesses the qualifications for global operations but has also entered a verifiable and sustainable “deep compliance zone” in its institutional framework. This is not a short-term compliance showcase, but a core part of the long-term trust strategy of BACXN.

Bitcoin Solaris Presale Hits Final Stretch: $7 Entry Before 233% Launch Surge, 10,000+ TPS Capacity Confirmed

TALLINN, Estonia, June 14, 2025 (GLOBE NEWSWIRE) -- Bitcoin Solaris (BTC-S), the rapidly growing decentralized network, has entered Phase 7 of its presale, with tokens now priced at just $7—a steep discount ahead of its $20 public launch price, marking a projected 233% return for early contributors.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFOR